Tunisia
8 Vaccines Approved for Use in Tunisia
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: santetunisie.rns.tn
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: sauve.tn
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: aa.com.tr
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: xinhuanet.com
Inactivated
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: sauve.tn
1 in Clinical Trials in Tunisia
DNA
Inovio
INO-4800
10 trials in 9 countries